50
Participants
Start Date
April 1, 2024
Primary Completion Date
April 30, 2025
Study Completion Date
September 30, 2025
Boya IVIG
"The initial dose and other dose changes will be determined by the investigator on a case-by-case basis aiming to prevent infection and minimum serum IgG levels of 5 g/L. The total number of doses administered will depend on the treatment regimen and run-in period:~* Between 16 and 20 intravenous injections for participants receiving infusions every 28 days, or;~* Between 21 and 25 intravenous injections for participants receiving infusions every 21 days"
Collaborators (1)
Boya Bio Pharmaceutical Group Co Ltd
UNKNOWN
Azidus Brasil
INDUSTRY